ENVALITH
株式会社メンタルヘルステクノロジーズ logo

Mental Health Technologies Co.,Ltd.

9218Growth MarketServices

株式会社メンタルヘルステクノロジーズ logo
Mental Health Technologies Co.,Ltd.9218

Business

Mental Health Technologies Co., Ltd., guided by its vision of "creating the standard for well-being," centers its operations on the Mental Health Solutions Business (47.4% of sales composition), which supports corporate industrial health and mental health measures, and the Medical Work Shift Business (50.8% of sales composition), which provides nursing assistant and medical office staffing services to medical institutions. The former's core offering is Sangyoi Cloud, which combines industrial physician and public health nurse service provision with the cloud service ELPIS, while the latter is operated by Task Force Co., Ltd., which became a wholly owned subsidiary in February 2024. Key customers are companies with 50 or more employees (approximately 100,000 domestic companies subject to the mandatory appointment of industrial physicians) and large acute-care hospitals. The company listed on the TSE Growth Market in March 2022.

Business Model

In the Mental Health Solutions Business, the company provides Sangyoi Cloud, which packages the provision of occupational physician and public health nurse services together with the cloud service ELPIS, on a monthly subscription basis, adopting a stock-type revenue model that accumulates MRR (monthly recurring revenue). The company aims to raise unit prices through additional proposals to ENT (client companies with 1,000 or more employees) customers. The Medical Work Shift Business is centered on staffing service revenue from nursing assistant dispatch. The company aims to expand the group through M&A and reduce overall group marketing costs by bringing digital marketing functions in-house.

Company Strengths

The number of ENT contracted groups expanded approximately 1.8x, from 125 groups at the end of December 2023 to 223 groups at the end of December 2025. NRR (net revenue retention) for ENT remained at 105% as of the end of December 2025, confirming a structure in which revenue from existing customers grows on a net basis. The ENT churn rate also remained at a low level throughout 2025.

MRR (monthly recurring revenue) increased continuously, with ENT rising from ¥91 million in Q4 2023 to ¥135 million in Q4 2025, and SMB rising from ¥69 million to ¥82 million over the same period. Through the monthly subscription model of Sangyoi Cloud, revenue expanded 4.4x over four fiscal periods, from ¥1,454 million in FY2021 to ¥6,435 million in FY2025.

Task Force holds a high share in nursing assistant staffing for large acute care hospitals in Aichi Prefecture, with its competitive advantage stemming from temporary staff who remain stably in place over long periods and a strong ability to propose operational improvements based on deep understanding of on-site work. In FY2025, revenue from the Medical Work Shift Business reached ¥3,269 million (full year).

ENVALITH's Perspective

In the first quarter of the fiscal year ending December 2026, revenue increased 20.3% year on year to ¥1,747 million, securing top-line growth, but on the profit side, operating profit declined significantly, down 16.2% year on year to ¥107 million, and ordinary profit fell 20.7% year on year to ¥94 million. The main causes cited are an increase in various expenses associated with the establishment of the shareholder benefit program and fees related to the acquisition of Include (commission expenses of ¥5,900 thousand, etc.), but as long as M&A activity continues, this represents a structure in which acquisition-related expenses recur repeatedly, and the risk of "one-off expenses" becoming a permanent fixture needs to be examined closely.

The company revised its medium-term management plan "MHT100/20-25," postponing the target achievement timing by one year to the fiscal year ending December 2028, and raising the consolidated revenue target from ¥10 billion to ¥15 billion. Meanwhile, the operating profit target remains unchanged at ¥2.0 billion, the lower bound under the previous plan. The full-year FY2026 (ending December 2026) earnings forecast calls for revenue of ¥9,252 million (up 43.8% year on year) and operating profit of ¥700 million (up 17.0% year on year), an aggressive plan, but first-quarter progress rates stood at only 18.9% for revenue and 15.4% for operating profit. It will be necessary to continue monitoring the consistency between a plan structure weighted toward the latter half of the year and the assumption of organic growth alone, excluding M&A effects.

Following the consolidation of Include as a subsidiary, long-term borrowings expanded to ¥2,493 million (up ¥383 million from the previous fiscal year-end), and the portion of long-term borrowings due within one year also increased to ¥578 million. The equity ratio declined from 25.5% at the previous fiscal year-end to 22.9%, and total net assets also decreased by ¥40 million from the previous fiscal year-end to ¥1,525 million. As an external factor, amid a continuing environment of rising interest rates, interest expenses expanded 26.7% year on year to ¥13 million. Together with the impairment risk associated with the goodwill balance of ¥1,988 million (34.3% of total assets), continuous monitoring of financial soundness, including the possibility of breaching financial covenants, is required.

Growth Strategy

Aiming for consolidated sales of ¥15.0 billion in FY2028 through ENT customer deepening, geographic expansion of medical staffing, and M&A

Continuing to enhance the content of "Sangyoi Cloud" services, promoting consulting-based sales proposals to large enterprises and unit price improvement through additional proposals to existing customers. Mental Health Solutions Business revenue for Q1 FY2026 (ending December 2026) grew steadily, up 16.2% year on year.

Acquired all shares of Include Co., Ltd., which operates a rework business (workplace reintegration support), making it a consolidated subsidiary effective March 31, 2026. Established an integrated service system spanning from prevention of mental health issues to early detection and return-to-work support. Goodwill of ¥294 million arose on a provisional basis (purchase price allocation not yet finalized).

Newly opened a Fukuoka branch to expand the sales area. Promoting differentiation and improved retention rates through skill-up training for dispatched staff and the establishment of a personnel evaluation system. Revenue for Q1 FY2026 (ending December 2026) maintained high growth, up 27.6% year on year to ¥906 million.

Revised the previous medium-term plan "MHT100/20-25," extending the target achievement timing by one year to FY2028 (ending December 2028) and raising the consolidated revenue target from ¥10.0 billion to ¥15.0 billion. The operating profit target is set at ¥2.0 billion. The plan is based solely on organic growth of the existing two businesses, and does not include any additional contribution from future M&A.

Last updated: July 17, 2026